BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32749871)

  • 1. The Utility of Gastrointestinal Endoscopic Examination Versus Positron Emission Tomography-Computed Tomography in the Detection of Second Primary Lesions in Korean Patients With Head and Neck Cancer.
    Kim MS; Song IS; Oh KH; Cho JG; Baek SK; Woo JS; Jung KY; Kwon SY
    Ear Nose Throat J; 2022 Feb; 101(2):NP50-NP57. PubMed ID: 32749871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chest radiography or chest CT plus head and neck CT versus
    Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
    Hanamoto A; Takenaka Y; Shimosegawa E; Ymamamoto Y; Yoshii T; Nakahara S; Hatazawa J; Inohara H
    Ann Nucl Med; 2013 Dec; 27(10):880-5. PubMed ID: 23979967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
    Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF
    Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic sensitivity of ¹⁸fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients.
    Kondo N; Tsukuda M; Nishimura G
    Eur Arch Otorhinolaryngol; 2012 May; 269(5):1503-7. PubMed ID: 21984059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distant metastases and synchronous malignancies on FDG-PET/CT in patients with head and neck cancer: a retrospective study.
    Flygare L; Al-Ubaedi A; Öhman W; Mo SJ
    Acta Radiol; 2020 Sep; 61(9):1196-1204. PubMed ID: 31902218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of PET and PET/CT in detecting upper gastrointestinal synchronous cancer in patients with head and neck carcinoma.
    Yabuki K; Kubota A; Horiuchi C; Taguchi T; Nishimura G; Inamori M
    Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):727-33. PubMed ID: 22722946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
    Wax MK; Myers LL; Gabalski EC; Husain S; Gona JM; Nabi H
    Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):703-7. PubMed ID: 12049568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
    Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
    Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT.
    Sun L; Wan Y; Lin Q; Sun YH; Zhao L; Luo ZM; Wu H
    World J Gastroenterol; 2010 Aug; 16(31):3964-9. PubMed ID: 20712059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.
    Agress H; Cooper BZ
    Radiology; 2004 Feb; 230(2):417-22. PubMed ID: 14699176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of chest CT scanning in the management of patients presenting with head and neck cancer.
    Houghton DJ; Hughes ML; Garvey C; Beasley NJ; Hamilton JW; Gerlinger I; Jones AS
    Head Neck; 1998 Oct; 20(7):614-8. PubMed ID: 9744461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
    Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
    Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management.
    Malik V; Johnston C; Donohoe C; Claxton Z; Lucey J; Ravi N; Reynolds JV
    Clin Nucl Med; 2012 Dec; 37(12):1152-8. PubMed ID: 23154472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome.
    Lee JS; Ahn JY; Choi KD; Song HJ; Kim YH; Lee GH; Jung HY; Ryu JS; Kim SB; Kim JH; Park SI; Cho KJ; Kim JH
    Korean J Intern Med; 2016 Mar; 31(2):253-9. PubMed ID: 26864297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
    Yamaga E; Toriihara A; Nakamura S; Asai S; Fujioka T; Yoshimura R; Michi Y; Harada H; Tateishi U
    Jpn J Clin Oncol; 2018 Jul; 48(7):633-639. PubMed ID: 29718274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
    Stokkel MP; Moons KG; ten Broek FW; van Rijk PP; Hordijk GJ
    Cancer; 1999 Dec; 86(11):2370-7. PubMed ID: 10590380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rigid Esophagoscopy for Head and Neck Cancer Staging and the Incidence of Synchronous Esophageal Malignant Neoplasms.
    McGarey PO; O'Rourke AK; Owen SR; Shonka DC; Reibel JF; Levine PA; Jameson MJ
    JAMA Otolaryngol Head Neck Surg; 2016 Jan; 142(1):40-5. PubMed ID: 26633039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of imaging modality for pre-treatment staging of head and neck cancer impacts TNM staging.
    Mur T; Sambhu KM; Mahajan A; Payabvash S; Fernandez J; Edwards HA
    Am J Otolaryngol; 2020; 41(6):102662. PubMed ID: 32858370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.